{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:09:58Z","timestamp":1788318598163,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.xjidi.2024.100292","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:24:45Z","timestamp":1717673085000},"page":"100292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation\u2019s 2019 Annual Survey"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-8041","authenticated-orcid":false,"given":"Melissa P.","family":"Zundell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-0775","authenticated-orcid":false,"given":"Alexis R.","family":"Ogdie-Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-7309","authenticated-orcid":false,"given":"Lourdes","family":"Perez-Chada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1768-6808","authenticated-orcid":false,"given":"Hassan","family":"Hamade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6468-0397","authenticated-orcid":false,"given":"George C.","family":"Gondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6360-1721","authenticated-orcid":false,"given":"Ali T.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-567X","authenticated-orcid":false,"given":"Stacie J.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3977-668X","authenticated-orcid":false,"given":"Zachary","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-4353","authenticated-orcid":false,"given":"Joseph F.","family":"Merola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-8618","authenticated-orcid":false,"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2024.100292_bib1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","article-title":"PROMIS\u00ae adult health profiles: efficient short-form measures of seven health domains","volume":"22","author":"Cella","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.xjidi.2024.100292_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.xjidi.2024.100292_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12955-020-01422-z","article-title":"Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire","volume":"18","author":"Coates","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.xjidi.2024.100292_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2009.09589.x","article-title":"Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis","volume":"162","author":"Dommasch","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A\u00a0patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.xjidi.2024.100292_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3899\/jrheum.160180","article-title":"Mapping the effect of psoriatic arthritis using the international classification of functioning, disability and health","volume":"44","author":"Gudu","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13075-021-02417-x","article-title":"Treatment persistence of biologics among patients with psoriatic arthritis","volume":"23","author":"Haddad","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.xjidi.2024.100292_bib8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.xjidi.2024.100292_bib9","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3899\/jrheum.150595","article-title":"Patient\u2019s global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity?","volume":"42","author":"Lubrano","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001170","article-title":"Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices","volume":"6","author":"Lubrano","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.xjidi.2024.100292_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40744-020-00229-0","article-title":"Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study","volume":"7","author":"Lubrano","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.xjidi.2024.100292_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40744-020-00207-6","article-title":"Depression in psoriatic arthritis: dimensional aspects and link with systemic inflammation","volume":"7","author":"Mathew","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.xjidi.2024.100292_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3899\/jrheum.130797","article-title":"Depression and anxiety in psoriatic disease: prevalence and associated factors","volume":"41","author":"McDonough","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archderm.141.1.19","article-title":"Members of the national psoriasis foundation: more extensive disease and better informed about treatment options","volume":"141","author":"Nijsten","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41927-019-0102-7","article-title":"Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States","volume":"4","author":"Ogdie","year":"2020","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib17","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/acr.24090","article-title":"Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with sex in 458 patients from fourteen countries","volume":"72","author":"Orbai","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.xjidi.2024.100292_bib18","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/acr.25112","article-title":"Persistence of biologics in the treatment of psoriatic arthritis: data from a large hospital-based longitudinal cohort","volume":"75","author":"Rida","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.xjidi.2024.100292_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/ker365","article-title":"Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone","volume":"51","author":"Rosen","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.xjidi.2024.100292_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kex387","article-title":"Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis","volume":"57","author":"Stober","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.xjidi.2024.100292_bib21","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3899\/jrheum.091315","article-title":"Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health","volume":"37","author":"Taylor","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.xjidi.2024.100292_bib22","author":"Terlizzi"},{"key":"10.1016\/j.xjidi.2024.100292_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jdv.14175","article-title":"The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis","volume":"31","author":"Wu","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2024.100292_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-019-04734-8","article-title":"Systematic review of mental health comorbidities in psoriatic arthritis","volume":"39","author":"Zhao","year":"2020","journal-title":"Clin Rheumatol"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026724000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:28:14Z","timestamp":1726446494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026724000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2667026724000390"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100292","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation\u2019s 2019 Annual Survey","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2024.100292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100292"}}